Kairos Pharma, Ltd. — Institutional Ownership

Which tracked institutions hold KAPA, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

3
Funds holding
$11928
Total value held
Buying
2 added/new · 0 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 State Street Corp $9247 24100 Held
2 Ubs Group Ag $2404 6261 +6261 NEW BUY
3 Barclays Plc $277 723 +723 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.